These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1422621)

  • 21. Do puerperal psychotic episodes identify a more familial subtype of bipolar disorder? Results of a family history study.
    Jones I; Craddock N
    Psychiatr Genet; 2002 Sep; 12(3):177-80. PubMed ID: 12218664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Management of women with bipolar disorders from conception through the postpartum period].
    Nordon C; Sutter AL; Verdoux H
    Presse Med; 2007 Dec; 36(12 Pt 3):1913-8. PubMed ID: 17572050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychosis as a predictor of response to lithium maintenance treatment in bipolar affective disorder.
    Rosenthal NE; Rosenthal LN; Stallone F; Fleiss J; Dunner DL; Fieve RR
    J Affect Disord; 1979 Dec; 1(4):237-45. PubMed ID: 162485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of postpartum psychosis and mania in women at high risk.
    Bergink V; Bouvy PF; Vervoort JS; Koorengevel KM; Steegers EA; Kushner SA
    Am J Psychiatry; 2012 Jun; 169(6):609-15. PubMed ID: 22407083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No association between two polymorphisms at the 5HT2A gene and bipolar affective puerperal psychosis.
    Robertson E; Jones I; Middle F; Moray J; Craddock N
    Acta Psychiatr Scand; 2003 Nov; 108(5):387-91. PubMed ID: 14531760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonresponse to reinstituted lithium prophylaxis in previously responsive bipolar patients: prevalence and predictors.
    Maj M; Pirozzi R; Magliano L
    Am J Psychiatry; 1995 Dec; 152(12):1810-1. PubMed ID: 8526252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of long-term (over 10 years) lithium therapy].
    Beresewicz M
    Psychiatr Pol; 1996; 30(4):583-91. PubMed ID: 8975259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders.
    Tondo L; Baldessarini RJ; Floris G; Rudas N
    Am J Psychiatry; 1997 Apr; 154(4):548-50. PubMed ID: 9090344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive-behavioral management of patients with bipolar disorder who relapsed while on lithium prophylaxis.
    Fava GA; Bartolucci G; Rafanelli C; Mangelli L
    J Clin Psychiatry; 2001 Jul; 62(7):556-9. PubMed ID: 11488368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bipolar affective puerperal psychosis associated with consanguinity.
    Craddock N; Brockington I; Mant R; Parfitt E; McGuffin P; Owen M
    Br J Psychiatry; 1994 Mar; 164(3):359-64. PubMed ID: 8199790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lithium discontinuation and subsequent effectiveness.
    Coryell W; Solomon D; Leon AC; Akiskal HS; Keller MB; Scheftner WA; Mueller T
    Am J Psychiatry; 1998 Jul; 155(7):895-8. PubMed ID: 9659853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timing of onset of lithium relapse prevention in bipolar disorder: evidence from randomised trials.
    Taylor MJ
    Br J Psychiatry; 2018 Nov; 213(5):664-666. PubMed ID: 30246666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Premenstrual relapse of puerperal psychosis.
    Brockington IF; Kelly A; Hall P; Deakin W
    J Affect Disord; 1988; 14(3):287-92. PubMed ID: 2968390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium prophylaxis of bipolar illness. The value of combination treatment.
    Peselow ED; Fieve RR; Difiglia C; Sanfilipo MP
    Br J Psychiatry; 1994 Feb; 164(2):208-14. PubMed ID: 7909713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic estrogen in recurrent postpartum affective disorder.
    Sichel DA; Cohen LS; Robertson LM; Ruttenberg A; Rosenbaum JF
    Biol Psychiatry; 1995 Dec; 38(12):814-8. PubMed ID: 8750040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder.
    Waters B; Lapierre Y; Gagnon A; Cahudhry R; Tremblay A; Sarantidis D; Gray R
    Biol Psychiatry; 1982 Nov; 17(11):1323-9. PubMed ID: 6817830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relapse in the first three months postpartum in women with history of serious mental illness.
    Taylor CL; Stewart RJ; Howard LM
    Schizophr Res; 2019 Feb; 204():46-54. PubMed ID: 30089534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
    Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of lithium prophylaxis in clinical practice.
    Markar HR; Mander AJ
    Br J Psychiatry; 1989 Oct; 155():496-500. PubMed ID: 2514958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.